Since Hh signaling has been linked to a variety of cancers, some of which develop in the setting of inflammation [29], [30], [31], we examined the role of Gli1, a known component of the Hh signaling pathway, in the transition from chronic inflammation to mucous neck cell metaplasia or SPEM. This evidence concerns the gene GLI1 and cancer.